Moreover, the survival analysis for patients with different tumor stage revealed that the high CCNB1 expression level was associated with shorter survival time compared with the low CCNB1 expression level in HCC patients with tumor stage 1 (log-rank P = 0.0088, Figure 4(g)), tumor stage 2 (log-rank P = 0.0071, Figure 4(h)), and tumor stage 3 (log-rank P = 0.0048, Figure 4(i)). This evidence concerns the gene CCNB1 and neoplasm.